EREG and colitis: PHD2 expression (i) reduces the number of TAMs in AOM/DSS tumors, (ii) impairs the protumorigenic properties of macrophages at least in part through decreased Ereg expression, and (iii) diminishes STAT3 and ERK1/2 signaling in colitis-associated tumors.